Tarceva (Erlotinib)
Tarceva (erlotinib) is a cancer medication that interferes with the growth and spread of cancer cells in the body. Tarceva is used to treat non-small cell lung cancer, pancreatic cancer, and certain types of head and neck cancer.
Do not use Tarceva if you are pregnant. It could harm the unborn baby. Use effective birth control while you are taking Tarceva and for at least 2 weeks after your treatment ends. Tell your doctor if you become pregnant during treatment with Tarceva or within 2 weeks after stopping it.
Tarceva may also be used for purposes not listed in this medication guide. Important information about Tarceva: You should not use Tarceva if you are allergic to erlotinib, or if you have squamous cell lung cancer that has spread to other parts of your body. Do not use Tarceva if you are pregnant. It could harm the unborn baby. Use effective birth control while taking Tarceva and for at least 2 weeks after your last dose.. Before using Tarcevia, tell your doctor if you have liver disease, bone marrow suppression, a weak immune system, or any type of infection.
Cancer medications like tarveca can be lifesaving for people fighting various forms on the disease but they come with risks as well such as potentially harmful interactions with other drugs a person takes as well potential serious side effects . Despite these risks however it’s important to remember that tarveca and similar drugs offer hope where often there was none before and so should always be considered as an option by those battling cancer.
1 review for Tarceva (Erlotinib)
Only logged in customers who have purchased this product may leave a review.
Tommy B –
I was recently prescribed Tarceva (erlotinib) for my non-small cell lung cancer. I have only been taking it for a few weeks, but so far I am really liking it! It seems to be keeping the cancer under control and my side effects have been minimal. I would definitely recommend this medication to anyone with NSCLC.